Haewon Chong joined the company in 2025 with extensive experience in technical sales from previous roles at AmbioPharm, Leinco Technologies, Medix Biochemica, and vivitide. Haewon has a proven track record of creating value through his strategic business development efforts and a passion for supporting biotech and pharma researchers. Today, he continues to drive business development initiatives at Arcinova, A Quotient Sciences Company.

Haewon holds a degree in Molecular Biology from the University of California, San Diego.